Cross‑Border Deal Watch · 2026-05-27 Daily Digest
No significant updates today.

Created by Yellow Paint
Timely US and European M&A news, deal rumors, private equity and LBO analysis for investors
Explore the latest content tracked by Cross‑Border Deal Watch
No significant updates today.
TEGNA's appointment of Patrick Paolini as CEO signals stability and revenue focus amid the blocked $6.2 billion Nexstar merger , giving investors a clearer view of leadership direction in this broadcasting deal.
HIG Capital is executing a buy-and-build strategy by acquiring majority control of Vítaly and integrating it into Avanta, creating one of Spain's...
Private equity firms are deploying performance metrics and AI tools to stand out amid tighter capital markets.
Eli Lilly is buying three clinical-stage vaccine developers for up to $3.8 billion, channeling obesity-drug profits into infectious-disease prevention...
Private equity firms are repositioning data centers as core infrastructure plays for the AI economy rather than niche real estate assets.
-...
Goldenpeak takes majority control of Ampere Analysis in its first deal since launching last year, providing the UK firm's initial institutional...
Shareholders backed the $1.65 billion Fortegra acquisition by DB Insurance with roughly 81% approval in December 2025, moving the deal to its expected May 29 close after ISS endorsed the process as the best option.
How do regulators assess acquisitions that might eliminate future competition from innovative startups?
Stellantis and Dongfeng will form a Europe-based JV (51:49 Stellantis-led) to handle sales, distribution, production, purchasing and engineering of...
CVC and Groupe Bruxelles Lambert have agreed to acquire Italian pharma company Recordati for €10.7bn ($12.4bn), a notable European PE-led buyout. The...
Timeline of Ryan Cohen's pursuit:
Super-majors are zeroing in on mid-tier producers (100k-500k oz gold equivalent) to sidestep lengthy permitting risks and capture quicker cash flows...
ADCs sustain M&A and licensing momentum by combining clinical validation with technical flexibility across targets, payloads, and conjugation approaches. Recent deals now extend beyond HER2/TROP-2 to platform tech, payloads, and ADC-adjacent formats.
Canada's new Defence Industrial Strategy enforces a strict “Build-Partner-Buy” framework that defaults to domestic production for 10 sovereign...
The author maintains a long-standing rule against investing in IPOs, arguing they occur when sellers maximize gains rather than when buyers...
Consumers Energy's bid to sell 13 Michigan hydroelectric dams to a Maryland private equity firm pits potential community preservation against fears of...